Professor Sangeeta Bhatia and her colleagues have successfully engineered bacteria that can be used to detect cancer and diabetes, writes Robert Service for Science. The researchers found that “while conventional imaging techniques struggle to detect liver tumors smaller than 1 square centimeter, this approach was able to flag tumors as small as 1 square millimeter.”
Los Angeles Times reporter Melissa Healy writes that researchers from MIT and the University of California, San Diego have successfully modified bacteria to detect cancer. “Their work is a key component of broader efforts to make the diagnosis and treatment of diseases such as cancer increasingly precise and targeted," writes Healy.
Researchers from MIT and the University of California, San Diego have genetically modified bacteria so that it can detect cancer, BBC News reports. The researchers hope that one day, “the general approach could one day be used to develop relatively cheap and easy to use home-testing kits for a range of diseases.”
MIT researchers have developed a non-invasive way to detect liver cancer using probiotics, reports Vijee Venkatraman for BetaBoston. The researchers found that they could “use bacteria as tumor scouts…and engineer them to emit a signal once they reached the mass and multiply.”
Boston.com reporter Dialynn Dwyer writes about how graduate student Steven Keating “fought his cancer with curiosity.” Dwyer explains that Keating “gathered his health data in order to understand the science behind what his body was going through” and even filmed his brain surgery.
Lindsay Kalter reports for The Boston Herald that MIT researchers are developing a device that can be implanted into a tumor to help determine the best course of cancer treatment. “We wanted to bring the laboratory into the human body,” says Langer.
BetaBoston reporter Nidhi Subbaraman writes about how graduate student Steven Keating's thirst for knowledge may have saved his life. After experiencing phantom odors, Keating urged his doctors to perform a brain scan, which revealed a tumor. Since then, Keating has “open-sourced” his illness, and become a “champion of a movement to provide patients with more information about their health.”
Steve Lohr of The New York Times writes about how allowing patients like brain cancer survivor and MIT graduate student Steven Keating greater access to their medical records can not only improve patient health, but also benefit medical research. The sharing of medical records could be a “huge crowdsourcing opportunity for research,” Keating explains.
In a New York Times article, Steve Lohr spotlights how graduate student Steven Keating’s active participation in his medical care led to early detection of a brain tumor. In describing patient access to medical records, Keating explains his belief that “data can heal.”
In a piece for The Huffington Post, Zeynep Ilyaz explains how Prof. Sangeeta Bhatia serves as an inspiration to her, citing her research advances in biotech and medicine, and her mentorship of women pursuing careers in STEM fields. “Dr. Bhatia is constantly looking for the next groundbreaking discovery in health, which makes her an excellent role model for girls and women,” Ilyaz writes.
NPR’s Jessica Harris speaks with Prof. Robert Langer about his pioneering work with drug delivery and tissue engineering. “My goals were to do things that I someday thought might improve people’s lives,” says Langer.
Washington Post reporter Annie Gowen writes about how MIT researchers have found that India’s latest swine flu outbreak may have mutated into a more dangerous strain. The researchers found “new mutations in the protein known to make the virus more virulent.”
Professor Ram Sasisekharan and research scientist Kannan Tharakaraman have found that a strain of H1N1 influenza in India is more virulent than health authorities have indicated, writes Rishi Lyengar of Time. “They found mutations in the Indian strains in a protein called hemagglutinin, which binds with receptors on the human body’s respiratory cells,” Lyengar writes.
Laura Santhanam writes for the PBS NewsHour that MIT researchers have found that a strain of swine flu in India is more dangerous than originally thought. The researchers found that “a mutation in the new H1N1 strain allows this form of swine flu to attack an infected person’s respiratory cells more virulently.”
Prof. Robert Langer speaks with Chris Baraniuk of New Scientist about winning the Queen Elizabeth Prize for Engineering and his career in biotechnology. “It’s going to be the entrepreneurs, the new professors, the young people who are willing to think outside the box and not necessarily go down a conventional path,” says Langer of the future of medicine.